Download the Case Study
Delivering the Only Approved Therapy for ANCA-Associated Vasculitis
Delivering the Only Approved Therapy for ANCA-Associated Vasculitis
Delivering the Only Approved Therapy for ANCA-Associated Vasculitis
Successfully delivering the only approved therapy for ANCA-associated vasculitis is a landmark achievement, and Medpace was proud to be the clinical research partner on this pivotal global Phase III trial.
Our industry-leading collaboration model and deep therapeutic expertise enabled us to navigate a rare, acute patient population across 20 countries. Learn how our integrated, global approach led to early enrollment and secured key regulatory approvals.
Your Next Breakthrough Starts Here
Leading Nephrology CRO
With decades of experience conducting phase I-IV nephrology clinical trials, Medpace is a globally recognized leader in renal clinical research. We understand the complexities of renal disease trials from the perspective of the Sponsor, the clinical investigator, the scientific leader, and the reviewer at regulatory agencies. Our seasoned medical in-house nephrologists, operational, and regulatory teams are fully embedded throughout your project – providing unmatched support for your program.
